Answers are grounded in this paper and cite their sources.
About one third of the world population has latent M. tuberculosis infection. This review explains the approach to patients with latent infection, including an update on the risks and benefits of treatment and assessment of the likelihood of progression to active disease.
No takes yet. Share an insight, caveat, or question.
Getahun et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: